| Ident. | Authors (with country if any) | Title |
|---|
| 000088 (2011) |
Emily Beth Devine [États-Unis] ; Rafael Alfonso-Cristancho [États-Unis] ; Sean D. Sullivan [États-Unis] | Effectiveness of Biologic Therapies for Rheumatoid Arthritis: An Indirect Comparisons Approach |
| 000105 (2012) |
M. Gallego-Galisteo ; A. Villa-Rubio ; E. Alegre-Del Rey [Espagne] ; E. Márquez-Fernández ; J. J. Ramos-Báez | Indirect comparison of biological treatments in refractory rheumatoid arthritis |
| 000143 (2012) |
Maxime Samson [France] ; Sylvain Audia [France] ; Nona Janikashvili [France] ; Marion Ciudad [France] ; Malika Trad [France] ; Jennifer Fraszczak [France] ; Paul Ornetti [France] ; Jean-Francis Maillefert [France] ; Pierre Miossec [France] ; Bernard Bonnotte [France] | Brief Report: Inhibition of interleukin‐6 function corrects Th17/Treg cell imbalance in patients with rheumatoid arthritis |
| 000228 (2012) |
Tomoyuki Imagawa [Japon] ; Syuji Takei [Japon] ; Hiroaki Umebayashi [Japon] ; Kenichi Yamaguchi [Japon] ; Yasuhiko Itoh [Japon] ; Toshinao Kawai [Japon] ; Naomi Iwata [Japon] ; Takuji Murata [Japon] ; Ikuo Okafuji [Japon] ; Mari Miyoshi [Japon] ; Yasuhiro Onoe [Japon] ; Yoshifumi Kawano [Japon] ; Noriko Kinjo [Japon] ; Masaaki Mori [Japon] ; Neelufar Mozaffarian [États-Unis] ; Hartmut Kupper [Allemagne] ; Sourav Santra [Inde] ; Gina Patel [États-Unis] ; Shinichi Kawai [Japon] ; Shumpei Yokota [Japon] | Efficacy, pharmacokinetics, and safety of adalimumab in pediatric patients with juvenile idiopathic arthritis in Japan |
| 000234 (2012) |
G. Lippi [Italie] ; G. Targher [Italie] | Optimal therapy for reduction of lipoprotein(a) |
| 000240 (2013) |
Naoshi Nishina [Japon] ; Yuko Kaneko [Japon] ; Hideto Kameda [Japon] ; Masataka Kuwana [Japon] ; Tsutomu Takeuchi [Japon] | Reduction of plasma IL-6 but not TNF-α by methotrexate in patients with early rheumatoid arthritis: a potential biomarker for radiographic progression |
| 000298 (2012) |
Yin Liu [États-Unis] ; Yuval Ramot [Israël] ; Antonio Torrelo [Espagne] ; Amy S. Paller [États-Unis] ; Nuo Si [République populaire de Chine] ; Sofia Babay [Israël] ; Peter W. Kim [États-Unis] ; Afzal Sheikh [États-Unis] ; Chyi-Chia Richard Lee [États-Unis] ; Yongqing Chen [États-Unis] ; Angel Vera [Espagne] ; Xue Zhang [République populaire de Chine] ; Raphaela Goldbach-Mansky [États-Unis, Israël] ; Abraham Zlotogorski [Israël] | Mutations in proteasome subunit β type 8 cause chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature with evidence of genetic and phenotypic heterogeneity |
| 000314 (2010) |
Ukihide Tateishi [Japon] ; Tomoyuki Imagawa [Japon] ; Noriko Kanezawa [Japon] ; Tetsuhiko Okabe [Japon] ; Kazuya Shizukuishi [Japon] ; Tomio Inoue [Japon] ; Shumpei Yokota [Japon] | PET assessment of disease activity in children with juvenile idiopathic arthritis |
| 000323 (2013) |
P. I. Novikov [Russie] ; I. O. Smitienko [Russie] ; S. V. Moiseev [Russie] | Tumor necrosis factor alpha inhibitors in patients with Takayasu's arteritis refractory to standard immunosuppressive treatment: cases series and review of the literature |
| 000326 (2015) |
Takeshi Sainoh [Japon] ; Sumihisa Orita [Japon] ; Masayuki Miyagi [Japon] ; Yoshihiro Sakuma [Japon] ; Kazuyo Yamauchi [Japon] ; Miyako Suzuki [Japon] ; Go Kubota [Japon] ; Yasuhiro Oikawa [Japon] ; Kazuhide Inage [Japon] ; Jun Sato [Japon] ; Kazuki Fujimoto [Japon] ; Yasuhiro Shiga [Japon] ; Gen Inoue [Japon] ; Yasuchika Aoki [Japon] ; Kazuhisa Takahashi [Japon] ; Seiji Ohtori [Japon] | Interleukin‐6 and interleukin‐6 receptor expression, localization, and involvement in pain‐sensing neuron activation in a mouse intervertebral disc injury model |
| 000337 (2011) |
Sylvie Fabre [France] | Approches pharmacologiques en immuno-rhumatologie |
| 000343 (2007) |
Norihiro Nishimoto [Japon] ; Jun Hashimoto [Japon] ; Nobuyuki Miyasaka [Japon] ; Kazuhiko Yamamoto [Japon] ; Shinichi Kawai [Japon] ; Tsutomu Takeuchi [Japon] ; Norikazu Murata [Japon] ; Désirée Van Der Heijde [Pays-Bas] ; Tadamitsu Kishimoto [Japon] | Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab |
| 000511 (2011) |
Stefan Kleinert [Allemagne] ; Hans-Peter Tony [Allemagne] ; Andreas Krause [Allemagne] ; Martin Feuchtenberger [Allemagne] ; Siegfried Wassenberg [Allemagne] ; Constanze Richter [Allemagne] ; Ekkehard Röther [Allemagne] ; Wolfgang Spieler [Allemagne] ; Holger Gnann [Allemagne] ; Bianca M. Wittig [Allemagne] | Impact of patient and disease characteristics on therapeutic success during adalimumab treatment of patients with rheumatoid arthritis: data from a German noninterventional observational study |
| 000520 (2013) |
C. Carnovale [Italie] ; V. Perrone [Italie] ; C. Borsadoli [Italie] ; A. Mambrini [Italie] ; A. Speziali [Italie] ; G. Froldi [Italie] ; S. Antoniazzi [Italie] ; L. Magistro [Italie] ; E. Clementi [Italie] ; S. Radice [Italie] | A case of urinary incontinence by hydroxychloroquine in a geriatric patient |
| 000674 (2013) |
Christoph Fiehn [Allemagne] ; Elisabeth Belke-Voss [Allemagne] ; Dietmar Krause [Allemagne] ; Siegfried Wassenberg [Allemagne] ; Rolf Rau [Allemagne] | Improved radiological outcome of rheumatoid arthritis: the importance of early treatment with methotrexate in the era of biological drugs |
| 000699 (2012) |
Young Ho Lee [Corée du Sud] ; Sang-Cheol Bae [Corée du Sud] ; Sung Jae Choi [Corée du Sud] ; Jong Dae Ji [Corée du Sud] ; Gwan Gyu Song [Corée du Sud] | The association between interleukin-6 polymorphisms and rheumatoid arthritis: a meta-analysis |
| 000748 (2012) |
Ariel C. Bulua [États-Unis] ; Douglas B. Mogul [États-Unis] ; Ivona Aksentijevich [États-Unis] ; Harjot Singh [États-Unis] ; David Y. He [États-Unis] ; Larry R. Muenz [États-Unis] ; Michael M. Ward [États-Unis] ; Cheryl H. Yarboro [États-Unis] ; Daniel L. Kastner [États-Unis] ; Richard M. Siegel [États-Unis] ; Keith M. Hull [États-Unis] | Efficacy of etanercept in the tumor necrosis factor receptor–associated periodic syndrome: A prospective, open‐label, dose‐escalation study |
| 000874 (2012) |
Ti Wen [République populaire de Chine] ; Yangguang Li [République populaire de Chine] ; Meng Wu [République populaire de Chine] ; Xiaolin Sun [République populaire de Chine] ; Xiucong Bao [République populaire de Chine] ; Yuquan Lin [République populaire de Chine] ; Jianlei Hao [République populaire de Chine] ; Lin Han [République populaire de Chine] ; Guangchao Cao [République populaire de Chine] ; Ziwen Wang [République populaire de Chine] ; Yuxiu Liu [République populaire de Chine] ; Zhenzhou Wu [République populaire de Chine] ; Zhangyong Hong [République populaire de Chine] ; Puyue Wang [République populaire de Chine] ; Liqing Zhao [République populaire de Chine] ; Zhanguo Li [République populaire de Chine] ; Qingmin Wang [République populaire de Chine] ; Zhinan Yin [République populaire de Chine] | Therapeutic effects of a novel tylophorine analog, NK‐007, on collagen‐induced arthritis through suppressing tumor necrosis factor α production and Th17 cell differentiation |
| 000875 (2012) |
Nicolino Ruperto [Italie] ; Pierre Quartier [France] ; Nico Wulffraat [Pays-Bas] ; Patricia Woo [Royaume-Uni] ; Angelo Ravelli [Italie] ; Richard Mouy [France] ; Brigitte Bader-Meunier [France] ; Sebastiaan J. Vastert [Pays-Bas] ; Emanuele Noseda [Suisse] ; Daniele D'Ambrosio [Suisse] ; Jean Lecot [Suisse] ; Abhijit Chakraborty [Suisse] ; Alberto Martini [Italie] ; Andrea Chioato [Suisse] | A phase II, multicenter, open‐label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features |
| 000924 (2012) |
Gyu-Tae Shin [Corée du Sud] ; Hwa Joung Lee [Corée du Sud] ; Heungsoo Kim [Corée du Sud] | GADD45γ regulates TNF-α and IL-6 synthesis in THP-1 cells |
| 000946 (2012) |
Eamonn S. Molloy [Irlande (pays)] ; Leonard H. Calabrese [États-Unis] | Progressive multifocal leukoencephalopathy associated with immunosuppressive therapy in rheumatic diseases: Evolving role of biologic therapies |
